diff --git a/tests/testthat/_snaps/listing_lbl02b.md b/tests/testthat/_snaps/listing_lbl02b.md index f927f50f..7f784fff 100644 --- a/tests/testthat/_snaps/listing_lbl02b.md +++ b/tests/testthat/_snaps/listing_lbl02b.md @@ -5,62 +5,62 @@ Output Listing of Laboratory Abnormalities Defined by NCI CTCAE Grade >= 2 - ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————— - Days Since NCI - Study Last Dose of Lab Normal CTCAE - Lab Test Treatment Center/Patient ID Day Date Study Drug Result Unit Range Grade - ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————— - Alanine Aminotransferase Measurement A: Drug X BRA-1/id-105 80 27MAY2020 0 4.3 U/L 7.0 - 55.0 L4 - 398 10APR2021 318 3.7 U/L 7.0 - 55.0 L3 - CAN-1/id-18 465 12APR2022 0 1.8 U/L 7.0 - 55.0 L2 - CHN-1/id-133 127 13DEC2020 0 5.6 U/L 7.0 - 55.0 L2 - 197 21FEB2021 70 1.2 U/L 7.0 - 55.0 L4 - CHN-1/id-199 277 11OCT2020 0 5.3 U/L 7.0 - 55.0 L4 - 672 10NOV2021 395 6.8 U/L 7.0 - 55.0 L2 - CHN-1/id-235 348 25JUN2020 0 3.0 U/L 7.0 - 55.0 L3 - CHN-1/id-275 364 01JUN2021 0 5.1 U/L 7.0 - 55.0 L2 - CHN-1/id-277 483 12MAY2022 0 1.1 U/L 7.0 - 55.0 L4 - CHN-1/id-287 182 23MAY2020 0 5.9 U/L 7.0 - 55.0 L2 - 191 01JUN2020 9 5.3 U/L 7.0 - 55.0 L3 - 515 21APR2021 324 2.9 U/L 7.0 - 55.0 L4 - CHN-1/id-315 289 05JUN2020 0 4.6 U/L 7.0 - 55.0 L4 - 599 11APR2021 310 5.2 U/L 7.0 - 55.0 L4 - CHN-1/id-316 971 14MAY2023 0 3.6 U/L 7.0 - 55.0 L4 - CHN-1/id-360 689 01APR2022 0 4.7 U/L 7.0 - 55.0 L2 - CHN-1/id-371 81 01MAY2021 0 5.9 U/L 7.0 - 55.0 L2 - CHN-1/id-47 236 11SEP2020 0 4.4 U/L 7.0 - 55.0 L3 - CHN-1/id-53 98 13FEB2020 0 6.4 U/L 7.0 - 55.0 L2 - 343 15OCT2020 245 3.6 U/L 7.0 - 55.0 L2 - CHN-1/id-62 228 08JUL2021 0 5.2 U/L 7.0 - 55.0 L4 - CHN-11/id-116 562 28SEP2021 0 5.7 U/L 7.0 - 55.0 L3 - CHN-11/id-124 590 23FEB2021 0 6.0 U/L 7.0 - 55.0 L3 - CHN-11/id-132 23 21MAR2020 0 3.3 U/L 7.0 - 55.0 L2 - CHN-11/id-167 243 08JUL2020 0 5.0 U/L 7.0 - 55.0 L4 - CHN-11/id-354 690 31DEC2021 0 3.5 U/L 7.0 - 55.0 L2 - CHN-11/id-379 220 06MAR2020 0 2.2 U/L 7.0 - 55.0 L3 - CHN-12/id-258 102 11JUN2020 0 0.5 U/L 7.0 - 55.0 L3 - 250 06NOV2020 148 0.5 U/L 7.0 - 55.0 L2 - CHN-12/id-396 328 13AUG2020 0 5.9 U/L 7.0 - 55.0 L2 - CHN-13/id-270 43 29SEP2019 0 2.8 U/L 7.0 - 55.0 L3 - CHN-14/id-161 123 13JAN2020 0 5.8 U/L 7.0 - 55.0 L3 - 875 03FEB2022 752 5.2 U/L 7.0 - 55.0 L2 - CHN-14/id-168 251 04FEB2020 0 5.1 U/L 7.0 - 55.0 L3 - CHN-14/id-228 448 08JAN2021 0 0.0 U/L 7.0 - 55.0 L2 - CHN-15/id-14 265 20JUN2020 0 3.5 U/L 7.0 - 55.0 L2 - 272 27JUN2020 7 4.9 U/L 7.0 - 55.0 L4 - CHN-17/id-182 522 21FEB2021 0 3.2 U/L 7.0 - 55.0 L4 - CHN-17/id-209 688 04NOV2022 0 1.2 U/L 7.0 - 55.0 L2 - CHN-17/id-309 344 05APR2020 0 0.4 U/L 7.0 - 55.0 L2 - CHN-2/id-22 79 04APR2021 0 3.3 U/L 7.0 - 55.0 L2 - 81 06APR2021 2 0.7 U/L 7.0 - 55.0 L4 - CHN-2/id-286 116 09SEP2019 0 3.4 U/L 7.0 - 55.0 L3 - 645 19FEB2021 529 1.8 U/L 7.0 - 55.0 L3 - CHN-2/id-367 220 02FEB2021 0 5.9 U/L 7.0 - 55.0 L4 - CHN-2/id-395 939 21NOV2021 0 4.0 U/L 7.0 - 55.0 L4 - CHN-2/id-398 299 13AUG2020 0 0.1 U/L 7.0 - 55.0 L2 - CHN-3/id-128 151 25JUL2019 0 2.4 U/L 7.0 - 55.0 L2 - 313 03JAN2020 162 6.6 U/L 7.0 - 55.0 L4 - ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————— + —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————— + Days Since NCI + Study Last Dose of Lab Normal CTCAE + Lab Test Treatment Center/Patient ID Day Date Study Drug Result Unit Range Grade + —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————— + Alanine Aminotransferase Placebo 705/1186 16 23JAN2014 0 104.0 U/L 6.0 - 32.0 H2 + 22 29JAN2014 6 107.0 U/L 6.0 - 32.0 H2 + 708/1286 167 23FEB2014 0 124.0 U/L 6.0 - 32.0 H2 + Xanomeline High Dose 705/1310 55 26DEC2013 0 129.0 U/L 6.0 - 32.0 H2 + Albumin Placebo 705/1349 26 04APR2013 0 29.0 g/dL 35.0 - 46.0 L2 + 53 01MAY2013 27 28.0 g/dL 35.0 - 46.0 L2 + 80 28MAY2013 27 28.0 g/dL 35.0 - 46.0 L2 + 136 23JUL2013 56 26.0 g/dL 35.0 - 46.0 L2 + 708/1286 167 23FEB2014 0 29.0 g/dL 35.0 - 46.0 L2 + Xanomeline Low Dose 705/1393 167 20FEB2013 0 28.0 g/dL 35.0 - 46.0 L2 + Alkaline Phosphatase Placebo 705/1186 -5 03JAN2014 0 565.0 U/L 35.0 - 115.0 H2 + 16 23JAN2014 21 672.0 U/L 35.0 - 115.0 H3 + 19 26JAN2014 3 601.0 U/L 35.0 - 115.0 H3 + 22 29JAN2014 3 657.0 U/L 35.0 - 115.0 H3 + 25 01FEB2014 3 651.0 U/L 35.0 - 115.0 H3 + 31 07FEB2014 6 686.0 U/L 35.0 - 115.0 H3 + 709/1339 168 08JUN2013 0 499.0 U/L 35.0 - 115.0 H2 + 184 24JUN2013 16 624.0 U/L 35.0 - 115.0 H3 + Xanomeline High Dose 703/1295 -28 24OCT2013 0 386.0 U/L 35.0 - 115.0 H2 + -17 04NOV2013 11 398.0 U/L 35.0 - 115.0 H2 + 15 05DEC2013 32 390.0 U/L 35.0 - 115.0 H2 + 28 18DEC2013 13 382.0 U/L 35.0 - 115.0 H2 + 42 01JAN2014 14 378.0 U/L 35.0 - 115.0 H2 + 56 15JAN2014 14 372.0 U/L 35.0 - 115.0 H2 + 90 18FEB2014 34 375.0 U/L 35.0 - 115.0 H2 + 113 13MAR2014 23 380.0 U/L 35.0 - 115.0 H2 + 180 19MAY2014 67 361.0 U/L 35.0 - 115.0 H2 + Anisocytes Placebo 701/1015 -7 26DEC2013 0 1.0 NO UNITS NA - NA NA + 701/1234 -10 20MAR2013 0 1.0 NO UNITS NA - NA NA + 701/1415 28 20OCT2013 0 1.0 NO UNITS NA - NA NA + 703/1042 27 28MAR2013 0 1.0 NO UNITS NA - NA NA + 704/1164 180 17MAR2013 0 1.0 NO UNITS NA - NA NA + 198 04APR2013 18 1.0 NO UNITS NA - NA NA + 704/1233 113 11JUL2013 0 1.0 NO UNITS NA - NA NA + 704/1351 -16 26SEP2013 0 1.0 NO UNITS NA - NA NA + -9 03OCT2013 7 1.0 NO UNITS NA - NA NA + 704/1388 27 02JAN2013 0 1.0 NO UNITS NA - NA NA + 55 30JAN2013 28 1.0 NO UNITS NA - NA NA + 83 27FEB2013 28 1.0 NO UNITS NA - NA NA + 143 28APR2013 60 1.0 NO UNITS NA - NA NA + 704/1445 15 25MAY2014 0 1.0 NO UNITS NA - NA NA + 705/1059 -3 02AUG2013 0 1.0 NO UNITS NA - NA NA + 123 05DEC2013 126 1.0 NO UNITS NA - NA NA + 705/1186 31 07FEB2014 0 1.0 NO UNITS NA - NA NA + 705/1349 80 28MAY2013 0 1.0 NO UNITS NA - NA NA + 183 08SEP2013 103 1.0 NO UNITS NA - NA NA + 706/1041 43 11FEB2014 0 1.0 NO UNITS NA - NA NA + 708/1087 118 16FEB2013 0 1.0 NO UNITS NA - NA NA + 708/1342 41 07FEB2013 0 1.0 NO UNITS NA - NA NA + 57 23FEB2013 16 1.0 NO UNITS NA - NA NA + —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————— NCI CTCAE grade is displayed as abnormal high (H) or low (L) followed by the grade. diff --git a/tests/testthat/test-listing_lbl02b.R b/tests/testthat/test-listing_lbl02b.R index 5eca4842..65453cdb 100644 --- a/tests/testthat/test-listing_lbl02b.R +++ b/tests/testthat/test-listing_lbl02b.R @@ -1,5 +1,5 @@ testthat::test_that("LBL02B listing is produced correctly", { - adlb_x <- adlb_raw %>% + adlb_x <- adlb_pharmaverse %>% filter( !sub("-", "", ATOXGR) %in% c("", "0", "1"), LBTEST != "", @@ -8,6 +8,7 @@ testthat::test_that("LBL02B listing is produced correctly", { ) %>% mutate( CPID = paste(SITEID, SUBJID, sep = "/"), + ADTM = ADT, ADTM = toupper(format(as.Date(ADTM), "%d%b%Y")), AVAL = format(round(AVAL, 1), nsmall = 1), LBNRNG = paste(format(round(ANRLO, 1), nsmall = 1), format(round(ANRHI, 1), nsmall = 1), sep = " - "),